Halberd Corporation
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a HALB research report →
Price Chart
About the company
Halberd Corporation is a biotechnology firm dedicated to pioneering therapies for neurodegenerative conditions. The company's therapeutic focus encompasses a broad range of serious illnesses, including post-traumatic stress disorder (PTSD) and chronic traumatic encephalopathy (CTE), Alzheimer's disease, Parkinson's disease, various forms of cancer, and disorders impacting the blood and cerebrospinal fluid. Established in 2009, Halberd Corporation operates from its headquarters in Jackson Center, Pennsylvania.
- CEO
- William A. Hartman
- IPO
- 2012
- Employees
- 3
- HQ
- Jackson Center, PA, US
Get TickerSpark's AI analysis on HALB
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $309.52K
- P/E
- -9.54
- PEG
- -0.10
- P/S
- 0.00
- P/B
- -0.49
- EV/EBITDA
- -11.57
- Div Yield
- 0.00%
- Gross Margin
- 0.00%
- Op Margin
- 0.00%
- Net Margin
- 0.00%
- ROE
- 5.01%
- ROIC
- 5.56%
Latest fiscal year · YoY change
- Revenue
- $0-100.0%
- Gross Profit
- $-549-165.2%
- Op Income
- $-18,665
- Net Income
- $-20,071+74.8%
- EPS
- $0.00+100.0%
- OCF Growth
- +0.0%
- FCF Growth
- +0.0%
- 52W High
- $0.00
- 52W Low
- $0.00
- 50D MA
- $0.00
- 200D MA
- $0.00
- Beta
- 0.13
- RSI (14)
- 40
- Avg Volume
- 744.72K
No earnings-call transcripts are available for HALB yet.
- Free Float
- 50.4%
- Shares Outstanding
- 515.88M
- Float Shares
- 260.12M
Our HALB coverage
Recent articles, reports, and earnings notes.
No research on HALB yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate HALB report →Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University
prismmediawire.com · Nov 3
Halberd Corporation Continues Seeking Government Contracts with Scientists at Mississippi State University
globenewswire.com · Nov 3
Halberd Corporation Successfully Demonstrates its Proprietary Breakthrough AI Technology for Behavioral Analysis Platform
prismmediawire.com · Oct 27
Halberd Corporation Acquires NeuroSense AI Corp., a Revolutionary Behavioral Intelligence Platform to Transform TBI, Other Research, and Clinical Assessment
prismmediawire.com · Sep 29
Halberd Corporation Acquires NeuroSense AI Corp., a Revolutionary Behavioral Intelligence Platform to Transform TBI, Other Research, and Clinical Assessment
globenewswire.com · Sep 29
Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
prismmediawire.com · May 28
Halberd, Athena GTX, Inc. & Athena Telemedicine Partnership, LLC Clinical Study Updates
globenewswire.com · May 28
Progress Update on Halberd, Athena GTX and Athena Telemedicine Partnership, LLC Joint Projects
prismmediawire.com · Mar 17
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.